Introduction
Cardiovascular disease is the leading cause of mortality in the world. Tissue engineering provides a viable alternative to create arterial grafts that can maintain vascular function comparable to native vessels. Fibrin is a suitable scaffold for creation of completely biological tissue-engineered grafts. For this study, a bioreactor system was designed to allow for culture of multiple grafts under similar conditions via a single flow loop that applies both cyclic distention and cyclic transmural flow for stimulating tissue growth.
Materials and Methods
A schematic of the bioreactor with mounted grafts is shown in Figure 1 along with grafts during static culture. A reciprocating syringe pump connects to the manifold through a 3-way valve, controlling pulse flow and stretch. Grafts of 2 and 4 mm diameter were cultured up to 9 weeks with a pulse frequency of 0.5 Hz and timeaverage distension amplitude (i.e. peak circumferential strain) of 7.3±1.9%. Harvested grafts were tested for burst pressure, compliance, suture retention strength, and collagen and cell concentrations. 
Results
The lumenal pressure and circumferential stretch were noninvasively monitored and used to calculate stiffness in the range of 80-120 mmHg and then to successfully predict burst strength as shown in Figure 2 . The length of the grafts was incrementally shortened during bioreactor culture to maintain circumferential alignment and achieve mechanical anisotropy comparable to native arteries (not shown). After 7-9 weeks of bioreactor culture, burst pressures were in the range of 1400-1600 mmHg, with compliances comparable to native arteries (Fig 3) . The suture retention strength was also suitable for implantation in the rat model based on rat aorta testing. 
Discussion and Conclusions
This pulsed flow-stretch bioreactor provides a method to grow multiple 4 mm vascular grafts with over 1500 mmHg burst pressure in just 9 weeks, and multiple 2 mm vascular grafts with nearly 1400 mmHg burst pressure in just 7 weeks. The 2 mm grafts possess suture retention strength comparable to the native rat aorta as well as physiological compliance and are thus considered implantable. The stiffness of the grafts, as measured from distension in the bioreactor between 80-120 mmHg, successfully predicts their burst pressure. Cyclic stretching of the grafts associated with the pulsed flow along with incremental shortening of the grafts during bioreactor culture are essential to the increases in collagen concentration and circumferential tissue alignment that correlate with graft strengthening. This bioreactor can be used to culture engineered grafts fabricated by any method and can facilitate development of grafts for clinical use.
